Tempest Therapeutics, Inc. Net Cash Provided by (Used in) Investing Activities, Continuing Operations
Tempest Therapeutics, Inc. (TPST) reported Net Cash Provided by (Used in) Investing Activities, Continuing Operations of $17.89 million for the 3-month period ending 2015-03-31, per its 10-Q filed 2015-05-11.
Discontinued › Cash Flow › Investing Activities
us-gaap:NetCashProvidedByUsedInInvestingActivitiesContinuingOperations · last filed 2015-05-11
- Tempest Therapeutics, Inc. net cash provided by (used in) investing activities, continuing operations for the quarter ending 2015-03-31 was $17.89M.
- Tempest Therapeutics, Inc. net cash provided by (used in) investing activities, continuing operations for the quarter ending 2014-12-31 was $4.66M, a 164.04% increase year-over-year.
- Tempest Therapeutics, Inc. net cash provided by (used in) investing activities, continuing operations for the quarter ending 2014-09-30 was $4.19M.
- Tempest Therapeutics, Inc. net cash provided by (used in) investing activities, continuing operations for the quarter ending 2014-06-30 was -$32.99M.
- Tempest Therapeutics, Inc. net cash provided by (used in) investing activities, continuing operations for fiscal 2014 was -$32.79M.
- Tempest Therapeutics, Inc. net cash provided by (used in) investing activities, continuing operations for fiscal 2013 was -$11.02M.
- Tempest Therapeutics, Inc. net cash provided by (used in) investing activities, continuing operations for fiscal 2012 was -$17.64M.
| Period end | Net Cash Provided by (Used in) Investing Activities, Continuing Operations 3 month | Net Cash Provided by (Used in) Investing Activities, Continuing Operations 6 month | Net Cash Provided by (Used in) Investing Activities, Continuing Operations 9 month | Net Cash Provided by (Used in) Investing Activities, Continuing Operations 12 month | Net Cash Provided by (Used in) Investing Activities, Continuing Operations 15 month | Net Cash Provided by (Used in) Investing Activities, Continuing Operations 18 month | Net Cash Provided by (Used in) Investing Activities, Continuing Operations 21 month | Net Cash Provided by (Used in) Investing Activities, Continuing Operations 24 month | Net Cash Provided by (Used in) Investing Activities, Continuing Operations 27 month | Net Cash Provided by (Used in) Investing Activities, Continuing Operations 30 month | Net Cash Provided by (Used in) Investing Activities, Continuing Operations 33 month | Net Cash Provided by (Used in) Investing Activities, Continuing Operations 36 month |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2015-03-31 | $17.89M 10-Q · filed 2015-05-11 | $22.55M derived: sum of 2 quarters · filed 2015-05-11 | $26.74M derived: sum of 3 quarters · filed 2015-05-11 | -$6.25M derived: sum of 4 quarters · filed 2015-05-11 | ||||||||
| 2014-12-31 | $4.66M derived: 10-K 12 month − 10-Q 9 month · filed 2015-03-16 | $8.85M derived: sum of 2 quarters · filed 2015-03-16 | -$24.14M derived: sum of 3 quarters · filed 2015-03-16 | -$32.79M 10-K · filed 2015-03-16 | ||||||||
| 2014-09-30 | $4.19M derived: 10-Q 9 month − 10-Q 6 month · filed 2014-11-10 | -$28.80M derived: sum of 2 quarters · filed 2014-11-10 | -$37.44M 10-Q · filed 2014-11-10 | -$35.68M derived: sum of 4 quarters · filed 2015-05-11 | ||||||||
| 2014-06-30 | -$32.99M derived: 10-Q 6 month − 10-Q 3 month · filed 2014-08-07 | -$41.63M 10-Q · filed 2014-08-07 | -$39.87M derived: sum of 3 quarters · filed 2015-05-11 | -$42.64M derived: sum of 4 quarters · filed 2015-05-11 | ||||||||
| 2014-03-31 | -$8.64M 10-Q · filed 2015-05-11 | -$6.88M derived: sum of 2 quarters · filed 2015-05-11 | -$9.64M derived: sum of 3 quarters · filed 2015-05-11 | -$19.48M derived: sum of 4 quarters · filed 2015-05-11 | -$37.30M 10-Q · filed 2014-05-08 | |||||||
| 2013-12-31 | $1.76M derived: 10-K 12 month − 10-Q 9 month · filed 2015-03-16 | -$1.00M derived: sum of 2 quarters · filed 2015-03-16 | -$10.83M derived: sum of 3 quarters · filed 2015-03-16 | -$11.02M 10-K · filed 2015-03-16 | -$28.66M 10-K · filed 2014-02-27 | |||||||
| 2013-09-30 | -$2.76M derived: 10-Q 9 month − 10-Q 6 month · filed 2014-11-10 | -$12.60M derived: sum of 2 quarters · filed 2014-11-10 | -$12.78M 10-Q · filed 2014-11-10 | -$29.62M derived: sum of 4 quarters · filed 2015-03-16 | -$30.42M 10-Q · filed 2013-11-13 | |||||||
| 2013-06-30 | -$9.83M derived: 10-Q 6 month − 10-Q 3 month · filed 2014-08-07 | -$10.02M 10-Q · filed 2014-08-07 | -$26.86M derived: sum of 3 quarters · filed 2015-03-16 | -$27.11M derived: sum of 4 quarters · filed 2015-03-16 | -$27.66M 10-Q · filed 2013-08-13 | |||||||
| 2013-03-31 | -$184.00K 10-Q · filed 2014-05-08 | -$17.03M derived: sum of 2 quarters · filed 2015-03-16 | -$17.27M derived: sum of 3 quarters · filed 2015-03-16 | -$17.39M derived: sum of 4 quarters · filed 2015-03-16 | -$17.82M 10-Q · filed 2013-05-15 | |||||||
| 2012-12-31 | -$16.84M derived: 10-K 12 month − 10-Q 9 month · filed 2015-03-16 | -$17.09M derived: sum of 2 quarters · filed 2015-03-16 | -$17.21M derived: sum of 3 quarters · filed 2015-03-16 | -$17.64M 10-K · filed 2015-03-16 | -$17.64M 10-K · filed 2013-02-25 | |||||||
| 2012-09-30 | -$248.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2013-11-13 | -$366.00K derived: sum of 2 quarters · filed 2013-11-13 | -$797.00K 10-Q · filed 2013-11-13 | -$797.00K 10-Q · filed 2012-11-13 | ||||||||
| 2012-06-30 | -$118.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2013-08-13 | -$549.00K 10-Q · filed 2013-08-13 | -$549.00K 10-Q · filed 2012-08-14 | |||||||||
| 2012-03-31 | -$431.00K 10-Q · filed 2013-05-15 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Aspire Biopharma Holdings, Inc. (ASBP) | United States | $0.012B | -0.60 |
| AEON Biopharma, Inc. (AEON) | United States | $0.013B | -0.36 |
| BIOVIE INC. (BIVI) | United States | $0.012B | |
| MUSTANG BIO, INC. (MBIO) | United States | $0.013B | |
| Vistagen Therapeutics, Inc. (VTGN) | United States | $0.013B | -0.14 |
| ADIAL PHARMACEUTICALS, INC. (ADIL) | United States | $0.012B | |
| Phio Pharmaceuticals Corp. (PHIO) | United States | $0.012B | -0.92 |
| Scienture Holdings, Inc. (SCNX) | United States | $0.012B | -0.38 |
| LISATA THERAPEUTICS, INC. (LSTA) | United States | $0.014B | -2.13 |
| KIORA PHARMACEUTICALS INC (KPRX) | United States | $0.012B |